Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
,7309902,time to peak level,"Following a single dose, SSA was promptly absorbed (mean time to peak level 1.5 hour) and was eliminated from plasma with a mean half-life of 1.1 hour.","Absorption, biotransformation, and pharmacokinetics of salicylsalicylic acid in humans. ",tmax-Q56,[Article Link](https://pubmed.ncbi.nlm.nih.gov/7309902/),h,1.5,30073,DB01399,Salsalate
,7309902,half-life,"Following a single dose, SSA was promptly absorbed (mean time to peak level 1.5 hour) and was eliminated from plasma with a mean half-life of 1.1 hour.","Absorption, biotransformation, and pharmacokinetics of salicylsalicylic acid in humans. ",t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/7309902/),h,1.1,30074,DB01399,Salsalate
,3956057,peak plasma SSA level,"Compared with control subjects, patients undergoing dialysis had a lower peak plasma SSA level (17 +/- 3 vs. 45 +/- 2 micrograms/ml; P less than 0.01) that occurred slightly later.",Salsalate kinetics in patients with chronic renal failure undergoing hemodialysis. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/3956057/),[μg] / [ml],17,102391,DB01399,Salsalate
,3956057,peak plasma SSA level,"Compared with control subjects, patients undergoing dialysis had a lower peak plasma SSA level (17 +/- 3 vs. 45 +/- 2 micrograms/ml; P less than 0.01) that occurred slightly later.",Salsalate kinetics in patients with chronic renal failure undergoing hemodialysis. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/3956057/),[μg] / [ml],45,102392,DB01399,Salsalate
,3956057,t1/2,"Therefore, the AUC for SA was increased by 50% and the SA t1/2 was prolonged in the patients receiving dialysis (8.1 +/- 0.7 vs 3.8 +/- 0.2 hours; P less than 0.01).",Salsalate kinetics in patients with chronic renal failure undergoing hemodialysis. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/3956057/),h,8.1,102393,DB01399,Salsalate
,3956057,t1/2,"Therefore, the AUC for SA was increased by 50% and the SA t1/2 was prolonged in the patients receiving dialysis (8.1 +/- 0.7 vs 3.8 +/- 0.2 hours; P less than 0.01).",Salsalate kinetics in patients with chronic renal failure undergoing hemodialysis. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/3956057/),h,3.8,102394,DB01399,Salsalate
